Japan's prime minister Shigeru Ishiba (second from the right) and health minister Takamaro Fukuoka (right) met with patients group on High-Cost Healthcare Benefit scheme on 7 March right before announcing the decision to halt its revision. (Cabinet Public Affairs Office of Japan)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
